These changes produces the characteristic sickle shape of the red cells, which is less pliable leading to episodes of microvascular occlusion and premature RBC destruction,leading to haemolytic anaemia. [1] To compensate for the reduced oxygen-carrying capacity, patients often have an increased plasma volume, elevated cardiac output and enlarged heart. Cardiomegaly is an expected consequence of the anaemia of SCD. [2] Cardiac complications are a common feature of SCD and are important cause of morbidity and mortality associated with this disease. In recent years, PH, a proliferative vascular disease of the lung, has been recognized as a major complication and an independent correlate with death among adults with SCD. For many decades, it was widely assumed that vascular occlusion by rigid red cells leading to tissue infarction was the sole cause of organ dysfunction in patients with SCD. This concept was supplemented in the late 20th century by evidence of cellular interactions between circulating blood cells and endothelial cells, suggesting dysfunction of the blood vessel wall in SCD. [3] During the last decade, it was demonstrated that chronic intravascular hemolysis may disturb nitric oxide bioavailability, promoting endothelial dysfunction, smooth muscle dystonia, enhancement of coagulopathy, and increased oxidant and inflammatory stress, all of which may lead to the development of proliferative changes seen in patients with pulmonary hypertension. [4] , [5] , [6] The chronic anemia of SCD results in an increased cardiac output. This results in increased stroke volume and dilation of the LV which leads to increased wall stress, increase in LV mass as well as impaired LV filling. [7] Recent studies using standard Doppler parameters and tissue Doppler have shown Diastolic dysfunction in adults and was considered as an independent risk factor for mortality. [8] II.
Material And Methods The study was conducted in the Department of Medicine, Pt. Jawaharlal Nehru Memorial Medical College and Dr. B.R.A.M. Hospital, Raipur (C.G.) among the patients presenting in O.P.D. and admitted in medicine ward from Dec. 2013 to Sep. 2015. A total of 100 patients were included fulfilling the inclusion criteria for the study. Patient's informed consent was taken. Detailed clinical history was recorded including age, sex, presenting complaints, past, personal and family history. All patients underwent complete clinical examination, laboratory investigation including Hb Electrophoresis and Doppler Echocardiography of patients were done. Transthoracic echocardiography was performed with the use of the Mindray M7 echocardiography machine. Cardiac measurements were performed according to American Society of Echocardiography guidelines .The LV ejection fraction was assessed using M-Mode with help of "Teichholz" equations. Tricuspid regurgitation jet velocity (TRV) was assessed and pulmonary hypertension was prospectively defined as a peak TR jet velocity of at least 2.5 m/s. Diastolic function was assessed in all patients using pulse doppler peak E and A velocities, E/A ratio, and deceleration time. 
Inclusion

III.
Observation And Results Total 100 cases were included in the study, out of which 33 cases (33%) were males and 67 (67%) were females. The ratio of male to female was 1: 2.03 and mean age was 29.4 years ± 11.77 years. 70 cases (70%) were AS and 30 (30%) were SS genotype in the study group. 
IV. Discussion
Genotype Analysis of study: Of the 100 patients included in the study, 70 were sickle cell trait (AS) and 30 were sickle cell disease (SS).There were 18 males and 52 females of sickle cell trait and there were 15 males and 15 females of sickle cell disease.The ratio of AS to SS was 2.3:1.Majority of patients in the study were of sickle cell trait then sickle cell disease.
Age and gender wise distribution of cases in our study:Among 100 patients included in our study 33 cases (33%) were male and 67 cases (67%) were females. The ratio of male and female in this study group is 1:2.03..The mean age of study population was 29.4 years ± 11.77 years.
There was female preponderance in our study in every age group . Maximum number of cases were in age group of 15-24 years in our study. Pathak J et al studied 50 patients of sickle cell disease, in which there were 34 were male (68%) and 16 were females (32%). Majority of patients i.e. 23 (46%) were in the age group 14-20 years, which is similar to our study. [9] In a study by Sachdev V et al out of 235 patients with documented SCD, 60 % cases were female 35±11 years as mean age . This study also shows female preponderance as our study. [8] 
Analysis Of Echocardiographic Findings:
In the present study, PH was defined in patients with sickle cell anemia who had TRV>2.5m/sec on echocardiography. In this study 24 patients had TR velocity ≥ 2.5 m/sec. Mean TRV in patients of group <2.5 m/sec (i.e. patients with no PH) was 0.76 ± 0.98 whereas Mean TRV in patients of group ≥ 2.5 m/sec (i.e. patients with PH) was 2.88 ± 0.34. This finding was statistically significant with P value <0.001. Out of 100 patients 44 patients had E/A <1, whereas 56 patients (56%) had E/A ≥ 1. Mean value of E/A = 0.9 ± 0.48 in patients with E/A <1, whereas mean value of E/A =1.26 ± 0.34 in patients with E/A ≥ 1. This was found to be statistically significant (p <0.001).
Mean Deceleration Time value in our population was 166.45 ± 38.82 msec with 312 msec as minimum value and 520 msec as maximum value.
In our study mean LVEF of study population was 66.80±8.24. Only 9 cases (9%) had LVEF < 55%. So we can conclude that systolic function is preserved in our patients.
Prevalence of LVDD in Sickle Cell study group:
In present study, out of 100 , 50 patients (50%) had Left ventricular diastolic dysfunction. Mean age of patient group with LVDD present was 28.82±11.05 whereas patients without LVDD had mean age of 29.98±12.65 years. Sachdev V et al assessed 141 sickle cell disease patients with the help of tissue Doppler imaging and evaluated the prevalence of diastolic dysfunction in them. They found that 25 patients (18%) had evidence of LV diastolic dysfunction. [ 
Association of LVDD with Age:
In this study majority of sickle cell disease patient i.e. 21 (50% cases of 42) among age group of 15-24 yrs had LVDD followed by 16 (55.17% of 29 patients) in the age group of 25-34 yrs. Mean age of men with diastolic dysfunction was 29.82 ± 10.24 yrs. Mean age of women with diastolic dysfunction was 29.37 ± 9.89 yrs. Onset of LVDD in our study population occurs at younger age group in both male and female as compared to Sachdev V et al study in which out of 235 patients with documented SCD with mean age of 35 ± 11 years, (range of age was 18 to 70 years) and 41 age-and gender-balanced control patients (mean age 37 ± 11 years)they found SCD patients with an E/A ratio of <1.0 were older than the remaining patients. [8] Zilberman et al in their study of 73 sickle cell patients didn't found any correlation between age and diastolic dysfunction. [10] Association between Haemoglobin (Hb) level and LVDD:
There were 13 cases (81.25 %) of LVDD out of 16 cases in Hb level group of 4-7 gm%.Out of 74 cases of Hb level 7-10 gm% 33 patients (44.59%) had LVDD.In Hb levels of >10 gm%, out of 10 cases, 4 (40%) had LVDD.So it is evident that diastolic dysfunction is associated low Hb levels. Mean Hb level in present study was 7.88 ± 1.81 gm% in patients with LVDD and 8.94 ± 1.49 gm% in patients without LVDD. Statistically it was found to be significant (p=0.006). Sachdev V et al in their study of 226 Sickle cell disease patients had LVDD, in which mean Hb level of 9.6± 1.8 gm% and control group of 41 patients had mean Hb level of 13.5 ± 1.6 gm%. This clearly shows association of LVDD with low Hb levels similar to our study. [8] Raj AB, Condurache T in their study of 22 patients with SCD found LVDD is more prevalent in severe anemia and it was found to be statistically significant (P = .003). [14] 
Prevalence of Pulmonary Hypertension in Sickle Cell population:
In our study 24 out of 100 sickle cell patients had PH of which 5 (20.83%) patients were male and 19 (79.16%) patients were female. Mean age for patients with PH was 28.92 ± 13.06 years and for patients without PH was 29.55 ± 11.51 years. In our study group 26.66% patients of sickle cell disease had PH as compared to 22.85% patients of sickle cell trait, but it was found to be statistically insignificant. Gladwin et al reported 32% of patients had pulmonary hypertension in a study consisting of 195 patients (82 men and 113 women; mean age, 36±12 years) of sickle cell disease. In their study they did not find any significant difference between sickle cell anemia and disease group. [15] Billy Brissac R et al reported a PH prevalence of 17% in their study of an adult population of 427 SCD patients with mean age of 37 years and mean PASP of 40 mm Hg. [16] Ambrusko et al had reported a 26% prevalence of PH in 44 patients of sickle cell anemia they studied. [17] Pashankar FD et al reported a prevalence of 30% Pulmonary Hypertension in 62 patient with sickle cell anemia. [18] Pulmonary Hypertension was identified by 58% patients with sickle cell anemia in a study of 38 patients in Canada by Ahmad et al. The estimated mean PASP was 37.5±10.9 mmHg. [19] Van beers EJ et al in their study of 85 patients of sickle cell anemia found a prevalence of PH in 41% patients. [20] Pathak J et al in their study found PH in 17(34%) patients out of 50 patients of sickle cell anemia. All studies mentioned above used a single echocardiography method as a screening tool to diagnose PH. [9] Analysis of Pulmonary Hypertension with Age:
There were 24 cases of PH in the study group. Mean age of women with PH was 29.37 ± 9.89 yrs. Mean age of men with PH was 29.82 ± 10.24 yrs. Statistically it was found to be non-significant (p=0.91).Pathak J et al in a study found that advance age groups among sickle cell patient have higher prevalence for PH. In their study 75% patients in age group of 31-40 years and 80% patients of age group > 40 years had PH. [9] Castro O et al in a study reported that prevalence of PH increases with age in SCD patients. In 40-49 years old prevalence was close to 40 % where as it increases up to60% by age of 50 and above. [21] Machado et al in their study stated that advance age was related to PH. In their study patients with PH, TRV>3m/sec had higher age (38±19 years) compared to those without PH, TRV<2.5 m/sec (34±10 years). [22] The National Institute of Health PH echocardiographic screening study (Haque A K et al) showed that patients with PH were significantly older than patients without PH. [23] In our study higher prevalence i.e. 50% among older age group ( > 55 years old), in contrast to younger age groups which had prevalence range from 10-30.90% of PH.
Analysis of Gender and Genotype in PH group:
In our study 24 patients had PH out of which 5 patients (20.83%) were male and 19 patients (79.16%) were female. In sickle cell trait (AS) population, 16 (22.85%) had PH while as in sickle cell disease (SS) Analysis of Pulmonary Hypertension with degree of Anemia: In our study 3 (18.75 % )out of 16 cases with 4-7 gm% Hb level had PH whereas in 7-10 gm% Hb group 21 cases (28.37 % )out of 74 cases had PH . None of 10 cases which had Hb level between 10 to 13 had PH. Patient with PH had mean Hb level of 8.58 gm% ± 1.85 gm%. In our study PH was more prevalent in patient with moderate to severe anemia than patients with mild anemia or near normal Hb level. Statistically it was found to be insignificant (p=0.59).Gladwin et al in their study noted that a lower Haemoglobin level was associated with a severe degree of PH. The mean Hb level of patients with PH was 8.5±2.0 as compared to 9.9±1.7 in patients without it. [15] Pathak j et al found in their study that mean haemoglobin level was lower in the group with PH. (mean Hb in Patient with PH was 4.49 gm% whereas in patient without PH mean Hb was 6.35gm %). [9] Association of Pulmonary Hypertension Group with Blood Pressure:
Gladwin et al in their study had a higher systolic blood pressure in PH group 123±23 mmHg as compared to119±15 mmHg in patient without PH. [15] Ataga et al also found similar findings in their study. [24] Pathak j et al did not found much variability in PH and Non PH group in their study. [9] In our study prevalence of PH was found to be statistically significant (p value is 0.03) in patients having relatively higher systolic blood pressure on admission.
Prevalence of both PH and LVDD in Sickle Cell population:
Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in patients with SCD..In our study 12(12%) patients had both LVDD and PH. Sachdev V et al in 141 patients of SCD found 11% patients had both PH and LV diastolic dysfunction. [8] The presence of both diastolic dysfunction and pulmonary hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p < 0.001).
Systolic function in Sickle Cell anemia:
In our study mean LVEF of study population was 66.80 ± 8.24, while in patients had PH mean LVEF was 66.50 ± 8.06 and in patients with LVDD mean LVEF was 66.46±8.93. Only 9 (9%) cases had LVEF < 55%, in which 5 patients had LVDD and 3 patients found to had PH. So we can conclude that systolic function is preserved in our patients. (p= 0.68 for LVDD patients and p=0.83 for PH patients, both were nonsignificant.).Sachdev V et al LV n their study of 235 sickle cell patients found systolic function did not impaired significantly (p = 0.2). The average LVEF was 65 ± 8% (range 42% to 83%), and only 9% of patients had evidence of systolic dysfunction with an ejection fraction <55%. [8] Batra et al found systolic function and contractility to be preserved in their study. [25] Taksande A et al in their prospective controlled study found that left ventricular contraction was good and systolic function was normal in study population. [26] 
V. Conclusion
We conclude that SCD patients have several problems with their heart function and heart vessels. The combination of moderate-to-severe anaemia and the resultant volume load produces increased cardiac output at rest. LV mass is increased secondary to compensatory hypertrophy that occurs in response to ventricular dilation, and the severity of dilation correlates with increasing degree of anaemia. Presence of both PH and LVDD significantly contributes to a higher mortality in patients of sickle cell anemia. Therefore by early detection we can start early treatment and can retard the progression of these cardiopulmonary abnormalities and its future consequences. Echocardiography using the latest sophisticated ultrasound techniques is a useful and irreplaceable non-invasive technique to study the changes in cardiac structure and function in SCD patients.
